Company Number: 14923808

Analysis Date: 2025-07-19 12:21 UTC

1. Industry Classification
   MY SHALLOM LIMITED operates within SIC code 86900, classified under "Other human health activities." This sector typically includes specialized health services not categorized under general medical practice or hospital activities, such as complementary therapies, health consultancy, or outpatient care services. The industry is characterised by high regulatory oversight, a growing demand driven by an aging population, and increasing consumer interest in personalized health services.

2. Relative Performance
   As a newly incorporated micro-entity (incorporated June 2023) with minimal financial disclosures for the year ending June 2024, MY SHALLOM LIMITED reports total net assets of £3,735 and fixed assets of £1,172. The company has a single employee, the director, indicating a very small operational scale typical of start-up or sole-trader conversions within this sector. Compared to industry standards where established providers often have substantial turnover and asset bases, this company remains at a nascent stage with no revenue or profit data disclosed yet. The micro-entity accounting framework exempts it from audit requirements, reflecting its minimal size and complexity.

3. Sector Trends Impact
   The human health activities sector is currently influenced by several trends: increased consumer focus on holistic and preventive health, digital health integration, and regulatory emphasis on quality and safety compliance. For small providers like MY SHALLOM LIMITED, these trends present both opportunities and challenges. Opportunities arise from niche service development and personalized care offerings; however, scalability and regulatory compliance costs may constrain growth. Additionally, post-pandemic shifts have increased demand for outpatient and alternative health services, potentially benefiting micro-entities agile enough to capture emerging client segments.

4. Competitive Positioning
   MY SHALLOM LIMITED appears as a niche micro-player within the broader human health activities sector, likely offering specialized or personalized services. Its strengths include low overhead costs and the flexibility inherent in a single-employee structure, enabling rapid decision-making and adaptation. However, the company faces significant challenges in brand recognition, resource limitations, and competitive pressures from larger clinics and established health service providers with broader service offerings and stronger capital bases. Without disclosed revenues or profitability, it is difficult to assess operational efficiency or market traction, but the current financials indicate a foundational stage rather than competitive scale.